1 October we become SureStone CapitalSame team, same ABN. Our website and email addresses move to surestone.com.au.

Company Interview / Market Update | Pro Medicus, Synlait Milk, Bravura Solutions, Mineral Resources

Loading

Preparing video

Market Update | Pro Medicus, Synlait Milk, Bravura Solutions, Mineral Resources

Company Interview29 Sep, 2025

Medical imaging group Pro Medicus has said it's exempt from the recent 100 per cent pharmaceutical tariffs announced by the Trump Administration last week. The company says it does not produce, sell or otherwise have any direct involvement with the pharmaceutical industry and as such, it is not subject to the recently announced US tariff on pharmaceuticals.

Synlait Milk is scaling down operations after reporting a NZ$800 thousand net profit after tax over FY25, in a period it described as challenging. Synlait will sell its New Zealand's North Island assets for NZ$307 million, in a bid to reduce debt and "refocus on core operations"

Elsewhere, wealth management software Bravura Solutions has appointed Colin Greenhill as its new CEO. His contract start on January 1st 2026, and Mr Greenhill will be based in London.

Mineral Resources has finished the upgrade of the Onslow Iron haul road in WA. The company says haulage is now due to resume at normal speed, with a widened road. Despite the set back, Mineral Resources shipped a record 3.2 million tonnes of ore in August 2025.

Copyright © 2026 Ausbiz Capital
Market Update | Pro Medicus, Synlait Milk, Bravura Solutions, Mineral Resources - Ausbiz Capital